# Predictive Value of PREMM5, MMRpredict, and Universal Tumor Screening for Lynch Syndrome in Vietnam

> **NCT06863038** · — · NOT_YET_RECRUITING · sponsor: **University of Medicine and Pharmacy at Ho Chi Minh City** · enrollment: 572 (estimated)

## Conditions studied

- Lynch Syndrome
- Colorectal Cancer (CRC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06863038
- **Lead sponsor:** University of Medicine and Pharmacy at Ho Chi Minh City
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-17
- **Primary completion:** 2027-03-17
- **Final completion:** 2027-11-30
- **Target enrollment:** 572 (ESTIMATED)
- **Last updated:** 2025-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06863038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06863038, "Predictive Value of PREMM5, MMRpredict, and Universal Tumor Screening for Lynch Syndrome in Vietnam". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06863038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*